BIOS Fund II, LP, 10% Owner at Lantern Pharma Inc. (LTRN), sold 6,445 shares at $5.20 ($34K) on 2022-09-02, disclosed to the SEC on 2022-09-07.
Open-market sale of $34k LTRN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.20 | 1,275 | $7K | 19.8% |
| 2 | $5.20 | 5,170 | $27K | 80.2% |
| Total | $5.20 avg | 6,445 | $34K | 100% |
| Filing → |
| INAB | BUY | 2022-08-17 | $6.7M | — | Filing → |